Global Neuropathology Market Overview
Neuropathology refers to the ailment of nerves resulting in pain and the numbness of limbs. Neuropathologists perform many tasks such as examination of biopsy from the brain and spinal cord for proper diagnosis of diseases. This biopsy is usually performed if a mass is detected via radiologic imaging. A neuropathologist also performs an autopsy by helping in the post-mortem diagnosis of numerous forms of neural conditions like dementia that affect the central nervous system.
Increasing prevalence of musculoskeletal conditions and rising technological advancements in medical diagnostic devices are some principal factors contributing to the ascension of the global neuropathology market through the forecast period. As per the recently released MRFR analysis, the global neuropathology market is anticipated to gain a 6% CAGR by the end of 2023.
With a rise in the prevalence of cerebrovascular disorders at a fast pace, the record has touched its highest peak in the recent past. This has resulted in a significant rise in the number of surgeries associated with the treatment of such disorders. Since neurosurgeries and spinal cord surgeries are critical in nature, continuous monitoring is necessary through the procedure, which also proves beneficial as the information can be recorded via electrical signals in real time.
Market Segmentation
The global neuropathology market is segmented in the latest MRFR analysis on the basis of test, application, end-users, and region. The global neuropathology market is segmented into body fluids, biopsy, tissue resections, and peripheral blood smears based on type. The biopsy segment is further sub-segmented into epidermal nerve fiber density testing (ENFD), bone-marrow biopsies, sural nerve biopsy test, and lymph node biopsies.
Based on application, the neuropathology market is segmented into perinatal disorders, cerebral hypoxia, CNS infections, brain tumors, demyelinating diseases, inherited metabolic disorders, neurodegenerative diseases, peripheral neuropathy, and myopathology.
Based on end-user, the neuropathology market is segmented into clinics, research centers, and hospitals.
Regional Analysis
The global neuropathology market is segmented into the Americas, Asia Pacific, Europe, and the Middle East & Africa. The Americas are further sub-segmented into North America and South America. North America is anticipated to own a principal share of the global neuropathology market during the forecast period. This market domination can be owed to the growing healthcare expenditure in North America since the beginning of 2016. The U.S. is estimated to lead regional neuropathology market due to the presence of premium hospitals in the U.S. Most of these hospitals, along with their neurology departments are well equipped with advanced equipment necessary to provide qualitative neuropathology services. Further, various organizations are creating awareness on different levels, regarding the benefits of neuropathology tests, promoting growth in the regional neuropathology market through the review period. Moreover, the country is developing an increasing number of academic courses to provide skilled personnel and match the demand for the same, leading to a high availability of neuropathology specialists in North America.
Europe is expected to follow North America and obtain the second largest market share for neuropathology, in the conjectured time period. Specifically, in neuropathology, Europe is witnessing fast-paced growth for brain tumors market. Additionally, European countries are estimated to make efforts in the promotion of benefits of intraoperative neurophysiological monitoring services, pushing the market to a great extent. Also, patient-friendly healthcare services, supportive insurance policies are projected to make a positive impact on the neuropathological market in Europe.
Asia Pacific is estimated to garner the fastest growth for the neuropathological market through the forecast period. Several factors are contributing to the ascension witnessed in the APAC region. One of these factors includes the rising expenditure on healthcare in Asia, owing to an extension of state healthcare programs. Also, the increasing affluence of the population, especially in India, is causative of the mounting expenditure by the government to enhance better healthcare provisions.
Key Players
The latest MRFR analysis has profiled the presence of many principal players in the global neuropathology market including RUP Laboratories, Therapath LLC, Abbott Laboratories, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Sakura Finetek USA Inc., Danaher Corporation, Quest Diagnostics Incorporated, Agilent Technologies Inc., and NeoGenomics Laboratories.
Industry Update
Scientists at the University of California have developed a machine learning tool that can detect if a sample of brain tissue has amyloid plaques and distinguish between the different types of amyloid plaques, at rocket speed. This machine learning tool can aid in the augmentation of the analysis of an expert neuropathologist. The tool also allows neuropathologists to analysis and research data thousands of times faster and wider, than it would be possible due to the lack of the tool.
Browse Related Reports at:
Blood Collection Market Research Report - Forecast to 2027 | MRFR
Irritable Bowel Syndrome Treatment Market Analysis, Growth Values and Forecast to 2027
Oxygen Therapy Equipment Market by Product, Portability, Applications and Global Forecast to 2027
No comments:
Post a Comment